HIV Drug Isentress Gains Expanded FDA Approval

Posted on

According to news sources, the drug Isentress (raitegravir) has been given expanded approval by The Food and Drug Administration to begin being used by those between 2-18 years of age.

The drug was first approved for adult usage back in October 2007 under the agency’s accelerated approval program, which aims to make the introduction of new drugs aimed at treating serious diseases to the market faster.

The drug was expanded for use by children and adolescents after a clinical trial including 96 children found that after 24 weeks of Isentress treatment, about 53 percent of patients showed no detectable amount of the virus in their blood.

The drug does not cure the HIV infection and should reportedly be used with other antiretroviral drugs to control illnesses associated with HIV.

As a Los Angeles product liability lawyer, I appreciate all efforts being made to ensure increased drug safety standards for everyone . I hope this information can help raise awareness about this product and keep consumers safe. If you or a loved one has been injured through the use or consumption of a defective product, speak with a personal injury lawyer Los Angeles to learn about the legal options available to you.